9 Meters Biopharma Operating Cash Flow 2011-2026 | NMTR

Annual Operating Cash Flow 9 Meters Biopharma

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-37.2 M	-29.5 M	-19.4 M	-18 M	-15.2 M	-5.1 M	-8.43 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-5.1 M	-37.2 M	-19 M

Quarterly Operating Cash Flow 9 Meters Biopharma

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-9.75 M	-	-27.5 M	-17.5 M	-9.75 M	-	-21.5 M	-13.3 M	-6.22 M	-	-13 M	-8.83 M	-2.63 M	-	-14.7 M	-10.8 M	-4.24 M	-	-12.8 M	-9.28 M	-6.97 M	-	-3.17 M	-2.05 M	-822 K	-	-6.24 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-822 K	-27.5 M	-10.1 M

Operating Cash Flow of other stocks in the Biotechnology industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-481 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	156 M	$ 21.91	2.34 %	$ 1.02 B	USA
I-Mab IMAB	-1.3 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	-169 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	-6.01 M	-	-18.52 %	$ 27.3 M	Britain
Aptorum Group Limited APM	-1.84 M	$ 0.94	5.23 %	$ 6.91 M	China
Biophytis SA BPTS	-23.8 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	99.9 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	158 M	$ 22.7	3.37 %	$ 3.76 B	USA
Advaxis ADXS	-29.5 M	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	22.7 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	-63.7 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	-116 M	-	-	$ 28.6 M	USA
AlloVir ALVR	-38.4 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	-8.56 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	-93.9 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	-8.58 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	-6.98 M	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	-55.2 M	-	-	$ 8.42 M	USA
Aptinyx APTX	-59.7 M	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	-18 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	-65.1 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	-29.1 M	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	890 M	$ 102.78	-2.55 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	-1.83 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	-65.7 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	-52.4 M	$ 4.16	1.84 %	$ 445 M	USA
Arcutis Biotherapeutics ARQT	-5.62 M	$ 23.75	2.09 %	$ 3.02 B	USA
Ayala Pharmaceuticals AYLA	-34.5 M	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	-284 M	$ 1.45	0.35 %	$ 386 M	Britain
Aptose Biosciences APTO	-22 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	5.96 B	-	-	$ 96.9 B	Britain
AVROBIO AVRO	-63.2 M	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	-8.95 M	$ 3.03	4.12 %	$ 4.99 M	Israel
BioDelivery Sciences International BDSI	41 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	1.13 B	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	-230 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	-733 M	-	-	$ 867 M	Germany
bluebird bio BLUE	-235 M	-	-	$ 546 M	USA
ContraFect Corporation CFRX	-46 M	-	-5.16 %	$ 5.39 M	USA
Cardiff Oncology CRDF	-37.9 M	$ 1.76	2.03 %	$ 118 M	USA
BioXcel Therapeutics BTAI	-57.6 M	$ 1.11	4.25 %	$ 13.6 M	USA
Cabaletta Bio CABA	-131 M	$ 3.02	2.43 %	$ 303 M	USA
Cara Therapeutics CARA	-23.5 M	-	-3.03 %	$ 260 M	USA
Allena Pharmaceuticals ALNA	-45.7 M	-	3.16 %	$ 1.9 M	USA
CASI Pharmaceuticals CASI	-26.8 M	-	-	$ 35.4 M	USA
CymaBay Therapeutics CBAY	-72.5 M	-	-	$ 3.45 B	USA